Series of 5-aryl-2-furamidines
    2.
    发明授权
    Series of 5-aryl-2-furamidines 失效
    5-芳基-2-糠酰胺系列

    公开(公告)号:US3919231A

    公开(公告)日:1975-11-11

    申请号:US56086975

    申请日:1975-03-21

    摘要: wherein A is 5-chloro-2-pyrimidinyl or
    WITH X representing hydrogen, nitro, amino, halo, dihalo, 4(lower)alkyl, 3-trifluoromethyl, 3,4-dimethoxy, 4-methyl-3chloro,4-alkoxy, 4-dimethylamino, 4-ethoxycarbonyl, 4-hydroxy, 4methyl thio, 4-(1-hydroxy)ethyl, or 4-acetyl, and R represents hydrogen or ethyl. These compounds are useful as antidepressants. Their useful antidepressant activity is exhibited in warm blooded animals under the standard ptosis-anti-tetrabenazine test. Thus, when administered perorally in suspension (0.5% aqueous methyl cellulose) or aqueous solution in doses ranging from 50 to 200 mg/kg to mice shortly prior to intraperitoneal administration of from 1-10 mg/kg of tetrabenazine, ptosis induced by tetrabenazine is curtailed to the extent of from 50-100%.

    A series of 5-aryl-2-furamidines are useful as antidepressants. This invention is concerned with a series of 5-aryl-2furamidines of the formula:

    摘要翻译: 一系列5-芳基-2-糠酰胺可用作抗抑郁药。